NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 0. It has been cited 131 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Research Institute
Grant: 63/313,823
Parker Institute for Cancer Immunotherapy
Grant: AGR-11611SOW1
Frederick National Laboratory for Cancer Research
Grant: HHSN261200800001E
National Institutes of Health
Grant: NKp30
Associazione Italiana per la Ricerca sul Cancro
Grant: IG2021\u2013ID26037
Department of Defense Peer Reviewed Cancer Research Program
Grant: W81XWH1910269
National Center for Advancing Translational Sciences
Grant: T32CA078207
Compagnia di San Paolo
Grant: 2019.866
NIAID NIH HHS
Grant: F31 AI164869
NCI NIH HHS
Grant: R01 CA201189
NCI NIH HHS
Grant: P30 CA196521
National Institutes of Health
Grant: RAI130760A
CCR NIH HHS
Grant: HHSN261200800001C
Associazione Italiana per la Ricerca sul Cancro
Grant: IG2021–ID26037
NIAID NIH HHS
Grant: R21 AI130760
Government of South Australia
Icahn School of Medicine at Mount Sinai
National Cancer Institute
Takeda Pharmaceuticals U.S.A.
Heron Therapeutics
University of Arizona
Novartis
U.S. Department of Defense
U.S. Department of Health and Human Services
FWCI
8.21
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals